Important Information for ModivCare Inc. Securities Holders: Rosen Law Firm Announces Class Action Lawsuit and Lead Plaintiff Deadline
On March 6, 2025, Rosen Law Firm, a global investor rights law firm, issued a press release reminding purchasers of securities of ModivCare Inc. (MODV) between November 3, 2022, and September 15, 2024 (the “Class Period”), of the important March 31, 2025, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that ModivCare and certain of its top executives made false and/or misleading statements and/or failed to disclose material information during the Class Period.
Background on ModivCare Inc.
ModivCare Inc. is a telehealth and remote patient monitoring services company that provides services to patients in their homes and other non-acute care settings. The company’s offerings include primary care, behavioral health, and chronic care management services, among others.
Allegations in the Lawsuit
The lawsuit alleges that ModivCare and certain of its executives made false and/or misleading statements and/or failed to disclose material information during the Class Period regarding the company’s financial condition and business prospects. Specifically, the complaint alleges that ModivCare failed to disclose:
- That the company was experiencing significant declines in revenue and patient volumes;
- That the company’s financial statements contained material misstatements;
- That the company was experiencing significant operational challenges;
- That the company’s business model was unsustainable;
- That the company’s financial results would be negatively impacted by these issues.
Effect on Individual Investors
If you purchased ModivCare securities during the Class Period, you may be able to recover your losses in a securities class action lawsuit. The lead plaintiff deadline to apply for appointment is March 31, 2025. If you wish to join the lawsuit, please contact Rosen Law Firm as soon as possible.
Effect on the World
The allegations in the ModivCare lawsuit are concerning for investors in the healthcare technology sector, as they highlight the importance of accurate financial reporting and transparency in the industry. The lawsuit also underscores the risks associated with investing in companies that are experiencing operational challenges and financial instability.
Conclusion
If you purchased ModivCare securities during the Class Period, it is important that you take action before the lead plaintiff deadline on March 31, 2025. Rosen Law Firm is dedicated to ensuring that all investors have the opportunity to recover their losses in securities class action lawsuits. For more information, please contact Rosen Law Firm at 866-767-3653 or via email at [email protected].
The allegations in the ModivCare lawsuit serve as a reminder of the importance of accurate financial reporting and transparency in the healthcare technology sector. As the industry continues to evolve, investors must remain vigilant and demand transparency from companies in order to make informed investment decisions.
Rosen Law Firm encourages investors to carefully monitor their holdings and seek professional advice if they have any concerns. The firm is committed to ensuring that all investors have the opportunity to recover their losses in securities class action lawsuits, and will continue to work tirelessly on behalf of its clients.
